Project

Pulmonary Vein Isolation with Pulsed-Field Ablation with versus without Posterior wall ablation in Patients with Symptomatic Persistent Atrial Fibrillation

Ongoing - recruitment active ยท 2024 until 2027

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2024
End Date
2027
Financing
Industry
Study Design
This is an investigator-initiated, multi-centre, randomized controlled, open-label trial with blinded endpoint adjudication
Brief description/objective

A multicentre randomised clinical trial comparing two ablation strategies for the treatment of persistent AF
(PVI only or PVI+ posterior wall ablation). IC: persistent AF, (N)OAK EC: atrial interventions, o. atrium >60mm, TAVI, Ml, >NYHA
III, LVEF <35%, amyloidosis, TIA/stroke), cardiomyopathy and others